AgenT Company
AgenT develops the first blood diagnosis to detect Alzheimer's disease from the asymptomatic stage.
Technology:
Neuropharmacology
Industry:
Biotechnology, Health Care, Health Diagnostics, Life Science, Neuroscience
Headquarters:
Paris, Ile-de-France, France
Founded Date:
2018-03-16
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
2
Total Funding:
3944995
Last Funding Date:
2021-07-01
Last Funding Type:
Seed
Register and Claim Ownership